Who owns WEREWOLF THERAPEUTICS INC?
- Ticker: HOWL
- CUSIP Number: 95075a107
Tip: Access positions for across all investors
Analyze quarterly positions in Werewolf Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Werewolf Therapeutics stock
Who bought or sold WEREWOLF THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RA Capital Management | 6.1M | $13M | 0% | Sep 2024 |
|
MPM Asset Management | 4.3M | $11M | 0% | Jun 2024 |
|
Partner Fund Management | 3.4M | $7.2M | 5% | Sep 2024 |
|
MPM Oncology Impact Management | 2.4M | $5.8M | 0% | Jun 2024 |
|
Bank of America Corporation | 2.2M | $4.6M | 0% | Sep 2024 |
|
BlackRock | 1.6M | $3.5M | 100% | Sep 2024 |
|
BlackRock | 1.6M | $3.9M | 863% | Jun 2024 |
|
Rubric Capital Management | 1.3M | $2.8M | 0% | Sep 2024 |
|
Vanguard Group | 1.3M | $3.2M | 20% | Jun 2024 |
|
Eagle Health Investments | 700k | $1.5M | 0% | Sep 2024 |
|
Geode Capital Management | 686k | $1.5M | 6% | Sep 2024 |
|
Sphera Funds Management | 627k | $1.5M | 0% | Jun 2024 |
|
DC Funds | 589k | $1.4M | 0% | Jun 2024 |
|
State Street Corporation | 424k | $1.0M | 496% | Jun 2024 |
|
Acadian Asset Management | 265k | $561k | 25% | Sep 2024 |
|
Dimensional Fund Advisors | 258k | $547k | 61% | Sep 2024 |
|
Two Sigma Advisers | 239k | $584k | -3% | Jun 2024 |
|
Alyeska Investment Group | 236k | $500k | 0% | Sep 2024 |
|
Verition Fund Management | 234k | $571k | -59% | Jun 2024 |
|
Northern Trust | 228k | $483k | 370% | Sep 2024 |
|
Two Sigma Investments | 219k | $535k | 19% | Jun 2024 |
|
Henderson Group | 168k | $407k | -90% | Jun 2024 |
|
Renaissance Technologies | 152k | $323k | -11% | Sep 2024 |
|
Bridgeway Capital Management | 125k | $305k | 47% | Jun 2024 |
|
Point72 Asset Management | 110k | $233k | -70% | Sep 2024 |
|
Charles Schwab Investment Management | 79k | $167k | 0% | Sep 2024 |
|
Murchinson | 63k | $153k | 100% | Jun 2024 |
|
Bank of New York Mellon | 58k | $123k | -14% | Sep 2024 |
|
Barclays | 55k | $116k | 130% | Sep 2024 |
|
Goldman Sachs Group | 52k | $127k | -70% | Jun 2024 |
|
Nuveen Asset Management | 52k | $127k | 100% | Jun 2024 |
|
Edgewood Management | 50k | $106k | 0% | Sep 2024 |
|
Morgan Stanley | 49k | $120k | 138% | Jun 2024 |
|
American Century Companies | 41k | $88k | 10% | Sep 2024 |
|
Alpine Partners VI | 38k | $92k | 100% | Jun 2024 |
|
Rhumbline Advisers | 28k | $60k | -13% | Sep 2024 |
|
Tower Research Capital | 24k | $58k | 126% | Jun 2024 |
|
Citigroup | 23k | $49k | 239% | Sep 2024 |
|
Sei Investments | 21k | $45k | 100% | Sep 2024 |
|
Deutsche Bank Aktiengesellschaft | 19k | $39k | 100% | Sep 2024 |
|
Mirae Asset Global Etfs Holdings | 17k | $36k | 100% | Sep 2024 |
|
Jane Street | 15k | $32k | -47% | Sep 2024 |
|
Camden Capital | 15k | $32k | 50% | Sep 2024 |
|
Regal Investment Advisors | 15k | $31k | 100% | Sep 2024 |
|
HBK Sorce Advisory | 14k | $29k | 3% | Sep 2024 |
|
Invesco | 14k | $29k | -3% | Sep 2024 |
|
SG Americas Securities | 14k | $29k | 100% | Sep 2024 |
|
Jpmorgan Chase & Co | 13k | $28k | 2% | Sep 2024 |
|
Wells Fargo & Company | 13k | $27k | 3% | Sep 2024 |
|
Citadel Advisors | 13k | $27k | -81% | Sep 2024 |
|
Engineers Gate Manager | 12k | $25k | 100% | Sep 2024 |
|
Balyasny Asset Management | 11k | $26k | -55% | Jun 2024 |
|
Qube Research & Technologies | 8.3k | $20k | -93% | Jun 2024 |
|
Financial Perspectives | 6.8k | $14k | 0% | Sep 2024 |
|
New York State Common Retirement Fund | 5.1k | $11k | -87% | Sep 2024 |
|
Simplex Trading | 3.4k | $7.0k | 2429% | Sep 2024 |
|
Royal Bank of Canada | 3.2k | $5.6k | 2% | Sep 2024 |
|
Summit Investment Advisors | 3.0k | $6.3k | 0% | Sep 2024 |
|
California State Teachers Retirement System | 2.2k | $4.7k | 0% | Sep 2024 |
|
TFC Financial Management | 1.5k | $3.2k | 0% | Sep 2024 |
|
Amalgamated Bank | 1.1k | $2.0k | 0% | Sep 2024 |
|
Point72 | 381.00 | $807.986700 | -97% | Sep 2024 |
|
CWM | 192.00 | $0 | 100% | Sep 2024 |
|
NISA Investment Advisors | 125.00 | $265.000000 | 100% | Sep 2024 |
|
Sterling Capital Management | 81.00 | $172.003500 | 100% | Sep 2024 |
|
Capital Performance Advisors | 60.00 | $127.002000 | 100% | Sep 2024 |
|
Who sold out of Werewolf Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Millennium Management | Jun 2024 | 1.1M | $2.7M |
Hrt Financial | Jun 2024 | 197k | $481k |
Marshall Wace | Jun 2024 | 134k | $327k |
Royce & Associates | Jun 2024 | 126k | $306k |
Man Group | Jun 2024 | 45k | $109k |
Cubist Systematic Strategies | Jun 2024 | 28k | $69k |
ExodusPoint Capital Management | Mar 2024 | 25k | $164k |
Squarepoint Ops | Mar 2024 | 25k | $159k |
Jump Financial | Jun 2024 | 21k | $52k |
OMERS Administration Corporation | Mar 2024 | 11k | $70k |
Sunrise Partners Limited Partnership | Jun 2024 | 10k | $25k |
Macquarie Group | Mar 2024 | 940.00 | $6.016000 |